Naturland Holding Zrt (BUD:NATURLAND) EBITDA per Share: Ft131.59 (TTM As of Jun. 2025)


BUD:NATURLAND Naturland Holding Zrt BUD:NATURLAND
61 GF Score
Price Ft2,820.00
GF Value Ft2,879.22
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Naturland Holding Zrt EBITDA per Share?

Naturland Holding Zrt BUD:NATURLAND 61 EBITDA per Share is Ft131.59 as of Jun. 2025. GuruFocus rates BUD:NATURLAND with a GF Score™ of 61/100 and a GF Value™ of Ft2,879.22 (Fairly Valued). The stock has 5 warning signs investors should review. Among 812 Drug Manufacturers companies, Naturland Holding Zrt ranks better than 51.11% on this metric.

Naturland Holding Zrt's EBITDA per Share for the six months ended in Jun. 2025 was Ft64.77. Its EBITDA per Share for the trailing twelve months (TTM) ended in Jun. 2025 was Ft131.59.

During the past 12 months, the average EBITDA per Share Growth Rate of Naturland Holding Zrt was 12.20% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Naturland Holding Zrt's EBITDA per Share or its related term are showing as below:

BUD:NATURLAND' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 9.4   Med: 54.05   Max: 98.7
Current: 9.4

During the past 5 years, the highest 3-Year average EBITDA per Share Growth Rate of Naturland Holding Zrt was 98.70% per year. The lowest was 9.40% per year. And the median was 54.05% per year.

BUD:NATURLAND's 3-Year EBITDA Growth Rate is ranked better than
51.11% of 812 companies
in the Drug Manufacturers industry
Industry Median: 8.9 vs BUD:NATURLAND: 9.40

Naturland Holding Zrt's EBITDA for the six months ended in Jun. 2025 was Ft895 Mil.

During the past 12 months, the average EBITDA Growth Rate of Naturland Holding Zrt was 12.20% per year. During the past 3 years, the average EBITDA Growth Rate was 9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 5 years, the highest 3-Year average EBITDA Growth Rate of Naturland Holding Zrt was 99.60% per year. The lowest was 9.90% per year. And the median was 54.75% per year.


Naturland Holding Zrt  (BUD:NATURLAND) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Naturland Holding Zrt EBITDA per Share Related Terms


Naturland Holding Zrt EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Naturland Holding Zrt's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturland Holding Zrt EBITDA per Share Chart

Naturland Holding Zrt Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA per Share
14.38 96.92 113.69 112.80 126.83

Naturland Holding Zrt Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
EBITDA per Share Get a 7-Day Free Trial Premium Member Only 55.57 57.23 60.01 66.82 64.77
BUD:NATURLAND
61GF Score
Naturland Holding Zrt BUD:NATURLAND
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturland Holding Zrt EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Naturland Holding Zrt's EBITDA per Share for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA per Share(A: Dec. 2024 )
=EBITDA/Shares Outstanding (Diluted Average)
=1752.296/13.816
=126.83

Naturland Holding Zrt's EBITDA per Share for the quarter that ended in Jun. 2025 is calculated as

EBITDA per Share(Q: Jun. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=894.839/13.816
=64.77

EBITDA per Share for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was Ft131.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of Ft131.59 mean?
Naturland Holding Zrt (BUD:NATURLAND) has a EBITDA per Share of Ft131.59 as of Jun. 2025. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Naturland Holding Zrt and its competitors. According to the industry distribution chart, Naturland Holding Zrt ranks #397 out of 812 companies in the Drug Manufacturers industry, placing it in the top 48.9%.
Is Naturland Holding Zrt's EBITDA per Share too high?
Naturland Holding Zrt's current EBITDA per Share is Ft131.59. Based on the distribution chart, Naturland Holding Zrt ranks #397 out of 812 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's EBITDA per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Naturland Holding Zrt ranks #397 out of 812 companies for EBITDA per Share. This puts Naturland Holding Zrt in the upper half of its industry. The industry median EBITDA per Share is 8.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Drug Manufacturers company?
The median EBITDA per Share among Drug Manufacturers companies is 8.90, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Naturland Holding Zrt and its competitors. For the Drug Manufacturers industry, the median EBITDA per Share is 8.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturland Holding Zrt's current EBITDA per Share is Ft131.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,879.22, compared to a current price of Ft2,820.00 — trading 2.1% below its estimated fair value. The current EBITDA per Share is Ft131.59. Naturland Holding Zrt's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current EBITDA per Share is Ft131.59 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?

Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued. The current stock price of Ft2,820.00 is trading 2.1% below its estimated GF Value™ of Ft2,879.22. GuruFocus considers Naturland Holding Zrt to be Fairly Valued.

Key valuation signals for BUD:NATURLAND:

  • EBITDA per Share: Ft131.59
  • GF Value™: Ft2,879.22 vs. price of Ft2,820.00 (2.1% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Naturland Holding Zrt Business Description

Address Csillagvirag utca 8, Budapest, HUN, 1106
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score

Get the complete analysis for BUD:NATURLAND

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft2,820.00
Price
Ft2,879.22
GF Value